Development of Nanomedicine for the Treatment of Breast Cancer Metastases
Kaushal, Neha
2017
Abstract
RhoC-GTPase, a member of the Ras-superfamily of small guanosine triphosphatases (GTPases), is over-expressed in advanced breast cancer and has been implicated in highly motile and invasive cancer phenotypes. The overexpression of RhoC mRNA in advanced breast cancers suggests that it plays a role as a transformative oncogene for human mammary epithelial cells and as a potential marker to screen breast cancer patients with highly aggressive tumors and provide therapeutic interventions prior to the development of metastases. Short interfering RNA (siRNA) inhibits RhoC protein expression resulting in the suppression of breast cancer metastasis by inhibiting cancer cell invasion and migration. Transforming anti-RhoC siRNA into a clinically-viable therapy requires the development of biocompatible delivery systems that incorporate a large dose of siRNA and shuttle the therapeutic payload into the cytoplasm of aggressive breast cancer cells. This dissertation describes the development of peptide targeted, degradable, pH-sensitive, membrane-destabilizing β-cyclodextrin (β-CD) polymers that proved effective in condensing anti-RhoC siRNA to form “smart” nanoparticles. The peptide targeted “smart” nanoparticles facilitated selective homing into target breast cancer cells through receptor-mediated endocytosis and achieved functional delivery of anti-RhoC siRNA past the endosome into the cytoplasm of breast cancer cells resulting in the efficient knockdown of RhoC mRNA and protein levels. Specifically, we utilized the varying reactivity of the primary and secondary hydroxyl groups of the β-CD core to develop asymmetric “smart” polymers. The secondary hydroxyl groups were modified with amphiphilic copolymers comprising of pH-sensitive dimethyl aminoethyl methacrylate (DMAEMA) and hydrophobic hexyl methacrylate (HMA) monomers incorporated at a 50/50 molar feed ratio and grafted via acid-labile hydrazone linkages to form β-CD-P(HMA-co-DMAEMA) polymers. The β-CD-P(HMA-co-DMAEMA) polymers were stable at physiological pH, but rapidly degraded into membrane-active fragments at the acidic pH of the endosome. The siRNA molecules were complexed to the P(HMA-co-DMAEMA) grafts following the partial conversion of DMAEMA monomers into cationic TMAEMA monomers. The β-CD-P(HMA-co-DMAEMA-co-TMAEMA) polymers delivered anti-RhoC siRNA into the cytoplasm of SUM149 and MDA-MB-231 cells resulting in a 80-90% and 90-100% reduction in RhoC mRNA and protein levels, respectively. The incorporation of peptide targeted moieties to the free ends of polyethylene glycol (PEG) brushes on the primary face of the β-CD core resulted in selective accumulation of “smart” nanoparticles in breast cancer cells overexpressing underglycosylated Mucin 1 (uMUC1) surface receptors both in vitro and in vivo. Further, combining the peptide ligands and anti-RhoC siRNA molecules on the same asymmetric nanoparticle demonstrated a synergistic reduction in breast cancer cell invasion and migration in vitro. These results collectively confirm the successful development of a targeted, degradable “smart” nanoparticles that can enhance the functional delivery of anti-RhoC siRNA into the cytoplasm of aggressive breast cancer cell both in vitro and in vivo.Subjects
siRNA delivery, breast cancer metastases
Types
Thesis
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.